FIRST AMENDMENT TO CONSULTING AGREEMENT
Exhibit 10.10
FIRST AMENDMENT TO CONSULTING AGREEMENT
This First Amendment to the Consulting Agreement (“Amendment”) is made as of December 16, 2023 (“Amendment Effective Date”) by and between Xxxxxx Xxxxx, Ph.D., having an address at 0 Xxxx Xxx., Xxx Xxxxxx XX 00000 (“Consultant”) and Allogene Therapeutics, Inc., a Delaware corporation having an address at 000 X. Xxxxx Xxx., Xxxxx Xxx Xxxxxxxxx, XX 00000 (“Allogene”).
WHEREAS, Consultant and Allogene have entered into that certain Consulting Agreement effective April 29, 2023 (“Agreement”), and
WHEREAS, the Parties desire to amend the Agreement.
NOW, THEREFORE, Consultant and Allogene hereby agree as follows:
1. The Term of the Agreement shall be extended to March 31, 2024.
2. The following sentence shall be added to the end of the Compensation section of Exhibit A of the Agreement:
“Beginning January 1, 2024, no vesting of any equity shall continue for Consultant under any existing Allogene Equity Incentive Plan; provided, however, that Consultant shall have three months to exercise their options upon the termination of this Agreement.”
3. Capitalized terms used but not defined herein shall have the meaning set forth in the Agreement. Except as specifically amended above, all terms and conditions of the Agreement shall remain in full force and effect and are hereby ratified and confirmed. In the event that there are any conflicts between the terms of this Amendment and the terms of the Agreement, the terms of this Amendment shall control. The terms of this Amendment shall be controlling over any terms of any purchase order, sales acknowledgement, quote, invoice, or other such documents issued by either party.
IN WITNESS WHEREOF, Consultant and Allogene have caused this Amendment to be duly executed and delivered as of the Amendment Effective Date written above.
XXXXXX XXXXX, Ph.D. | ALLOGENE THERAPEUTICS, INC. | ||||||||||
By: /s/ Xxxxxx Xxxxx | By: /s/ Xxxxxxx Xxxxx | ||||||||||
Date: 12/17/2023 | Name: Xxxxxxx Xxxxx | ||||||||||
Title: Vice President, Corporate Counsel | |||||||||||
Date: 12/15/2023 |